The Federal Antimonopoly Service (FAS) has agreed on the maximum selling price of a drug against COVID-19 called Favipiravir, Interfax reports.
It is noted that a package of this medicine with 50 tablets in the regions will cost up to 5,500 rubles, excluding regional markups, one piece will cost 100 rubles.
Meanwhile, in the capital's pharmacies, "Favipiravir" can be purchased for 6,875 rubles, while now the price of the drug varies from 11,000 to 16,000 rubles.
Thus, the maximum selling price for the drug has been reduced by more than 50 percent.
Recall that in September, the Ministry of Health of the Russian Federation authorized the outpatient use of two domestic drugs for coronavirus infection with the international non-proprietary name Favipiravir - Coronavir and Areplivir. Prior to that, they could only be used for treatment in hospitals strictly under the supervision of a doctor.
Earlier, the government decided to include Favipiravir in the list of vital and essential medicines.
Meanwhile, Rospotrebnadzor responded to data on the side effects of drugs for the new coronavirus.